Investment Focus
Artificial Intelligence
Digital Media
3D Printing
eCommerce
Autonomous Technology
Biotech
Overview
- Type: Index Equity
- Typical # of Holdings: 35-45
- Inception: Sept. 2017
- Portfolio Manager: Catherine Wood
- Analyst: Collective Team
Strategy Description
This index-based equity strategy seeks to provide investment results that closely correspond, before fees and expenses, to the performance of the ARK Israeli Innovation Index, which is designed to track the price movements of exchange-listed Israeli companies whose main business operations are causing disruptive innovation in the areas of genomics, health care, biotechnology, industrials, manufacturing, the Internet or information technology. The Index includes equity securities and depositary receipts of exchange listed companies that are incorporated and/or domiciled in Israel (‘‘Israeli Companies’’) and are included in one of the following economic sectors as defined by FactSet Research Systems: (i) health technology, (ii) communications, (iii) technology services, (iv) electronic technology, (v) consumer services, or (vi) producer manufacturing.
Availability
Strategy | ETF | Managed Account |
---|---|---|
ARK Israel Innovative Technology |
The content presented does not constitute investment advice, should not be used as the basis for any investment decision, and does not purport to provide any legal, tax or accounting advice. Certain of the statements contained on this website may be statements of future expectations and other forward-looking statements that are based on ARK’s current views and assumptions, and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. Please remember that there are inherent risks involved with investing in the markets, and your investments may be worth more or less than your initial investment upon redemption. There is no guarantee that ARK’s objectives will be achieved. Further, there is no assurance that any strategies, methods, sectors, or any investment programs herein were or will prove to be profitable, or that any investment recommendations or decisions we make in the future will be profitable for any investor or client. Professional money management is not suitable for all investors. For full disclosures, please go to our Terms & Conditions page.
Targeted Exposure to Israeli Innovation
Equal market capitalization weighting
Investment Team

Catherine Wood
Chief Executive Officer
Chief Investment Officer

Catherine Wood
Chief Executive Officer
Chief Investment Officer
Articles from Catherine Wood:
See all articles
Brett Winton
Chief Futurist
ARK Venture Investment Committee Member

Brett Winton
Chief Futurist
ARK Venture Investment Committee Member
Articles from Brett Winton:
See all articles
Tasha Keeney, CFA
Director of Investment Analysis and Institutional Strategies

Tasha Keeney, CFA
Director of Investment Analysis and Institutional Strategies
Articles from Tasha Keeney, CFA:
See all articles
Renato Leggi, CFA, CAIA
Client Portfolio Manager

Renato Leggi, CFA, CAIA
Client Portfolio Manager
Articles from Renato Leggi, CFA, CAIA:
See all articles
Simon Barnett
Director of Research, Life Sciences

Simon Barnett
Director of Research, Life Sciences
Articles from Simon Barnett:
See all articles
Alexandra Urman
Analyst

Alexandra Urman
Analyst
Articles from Alexandra Urman:
See all articles
Yassine Elmandjra
Analyst

Yassine Elmandjra
Analyst
Articles from Yassine Elmandjra:
See all articles
Nicholas Grous
Associate Portfolio Manager

Nicholas Grous
Associate Portfolio Manager